{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:56:26Z","timestamp":1788303386933,"version":"build-2803163510"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2008,5,7]],"date-time":"2008-05-07T00:00:00Z","timestamp":1210118400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0002089","type":"journal-article","created":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T22:23:28Z","timestamp":1210112608000},"page":"e2089","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Antibiotic Innovation May Contribute to Slowing the Dissemination of Multiresistant Streptococcus pneumoniae: The Example of Ketolides"],"prefix":"10.1371","volume":"3","author":[{"given":"Lulla","family":"Opatowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Temime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Varon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Leclerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Drugeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Bo\u00eblle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Guillemot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2008,5,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/milmed\/165.suppl_2.35","article-title":"The state of antibiotic resistance surveillance: an overview of existing activities and new strategies.","volume":"165","author":"SR Davis","year":"2000","journal-title":"Mil Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1093\/clinids\/24.Supplement_1.S85","article-title":"Antibiotic resistance in <italic>Streptococcus pneumoniae<\/italic>.","volume":"24","author":"A Tomasz","year":"1997","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1038\/nm1145","article-title":"Antibacterial resistance worldwide: causes, challenges and responses.","volume":"10","author":"SB Levy","year":"2004","journal-title":"Nat Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2105\/AJPH.90.2.223","article-title":"Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995\u20131997.","volume":"90","author":"DR Feikin","year":"2000","journal-title":"Am J Public Health"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(05)65585-7","article-title":"Carriage of pneumococci after pneumococcal vaccination.","volume":"348","author":"SK Obaro","year":"1996","journal-title":"Lancet"},{"key":"ref6","article-title":"Annual Report 2005.","year":"2006"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jama.285.5.601","article-title":"Development of antimicrobial agents in the era of new and reemerging infectious diseases and increasing antibiotic resistance.","volume":"285","author":"GH Cassell","year":"2001","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein\u2013polysaccharide conjugate vaccine.","volume":"348","author":"CG Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant <italic>Streptococcus pneumoniae<\/italic>.","volume":"354","author":"MH Kyaw","year":"2006","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1001\/jama.298.15.1772","article-title":"Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children.","volume":"298","author":"ME Pichichero","year":"2007","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10096-007-0321-5","article-title":"Antimicrobial use in Europe and antimicrobial resistance in <italic>Streptococcus pneumoniae<\/italic>.","volume":"26","author":"S Riedel","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref12","article-title":"Indices et series statistiques. Demographie.","year":"2007"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1086\/381547","article-title":"Nasopharyngeal carriage of <italic>Streptococcus pneumoniae<\/italic> by adults and children in community and family settings.","volume":"38","author":"G Regev-Yochay","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/infdis\/132.1.55","article-title":"Spread of S<italic>treptococcus pneumoniae<\/italic> in families. I. Carriage rates and distribution of types.","volume":"132","author":"JO Hendley","year":"1975","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1086\/516103","article-title":"Duration of nasopharyngeal carriage of penicillin-resistant <italic>Streptococcus pneumoniae<\/italic>: experiences from the South Swedish Pneumococcal Intervention Project.","volume":"25","author":"K Ekdahl","year":"1997","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1017\/S0950268804001980","article-title":"Estimating the transmission parameters of pneumococcal carriage in households.","volume":"132","author":"A Melegaro","year":"2004","journal-title":"Epidemiol Infect"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2334-6-14","article-title":"<italic>S. pneumoniae<\/italic> transmission according to inclusion in conjugate vaccines: Bayesian analysis of a longitudinal follow-up in schools.","volume":"6","author":"S Cauchemez","year":"2006","journal-title":"BMC Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1128\/JCM.01913-06","article-title":"Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci.","volume":"45","author":"L Hogberg","year":"2007","journal-title":"J Clin Microbiol"},{"key":"ref19","first-page":"862","article-title":"Advice of the French Superior Council on Public Health (section on transmissible diseases) relative to vaccination by heptavalent pneumococcal conjugate vaccine (Prevenar). Meeting of March 8, 2002.","volume":"9","year":"2002","journal-title":"Arch Pediatr"},{"key":"ref20","first-page":"1","article-title":"Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices for use of PCV7 in the USA.","volume":"49","year":"2000","journal-title":"MMWR"},{"key":"ref21","first-page":"177","article-title":"Updated recommendations for use of pneumococcal conjugate vaccine.","volume":"53","year":"2004","journal-title":"MMWR"},{"key":"ref22","first-page":"212","article-title":"Calendrier vaccinal 2006.","volume":"29\u201330","year":"2006","journal-title":"Bulletin Epid\u00e9miologique Hebdomadaire"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/AAC.48.6.2206-2213.2004","article-title":"Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance.","volume":"48","author":"L Temime","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.inf.0000210460.21966.f1","article-title":"Pneumococcal resistance in the postvaccine era.","volume":"25","author":"L Temime","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"ref25","article-title":"French Surveillance of Antimicrobial Consumption Program, CNAM-TS and CANAM."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.1365-2958.1999.01521.x","article-title":"beta-lactam resistance in <italic>Streptococcus pneumoniae<\/italic>: penicillin-binding proteins and non-penicillin-binding proteins.","volume":"33","author":"R Hakenbeck","year":"1999","journal-title":"Mol Microbiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1128\/AAC.49.11.4635-4640.2005","article-title":"Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in <italic>Streptococcus pneumoniae<\/italic> with increasing resistance to macrolides.","volume":"49","author":"AK Wierzbowski","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref28","first-page":"11","article-title":"Will resistance to ketolides develop in <italic>Streptococcus pneumoniae<\/italic>?","volume":"44","author":"R Leclercq","year":"2002","journal-title":"J Infect"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3201\/eid1109.050415","article-title":"Telithromycin-resistant <italic>Streptococcus pneumoniae<\/italic>.","volume":"11","author":"F Goldstein","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3201\/eid1106.050222","article-title":"Emergence and spread of <italic>Streptococcus pneumoniae<\/italic> with erm(B) and mef(A) resistance.","volume":"11","author":"DJ Farrell","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/48.suppl_2.9","article-title":"Overcoming antimicrobial resistance: profile of a new ketolide antibacterial, telithromycin.","volume":"48","author":"R Leclercq","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/jac\/dkh342","article-title":"No significant decrease in antibiotic use from 1992 to 2000, in the French community.","volume":"54","author":"A Sommet","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"ref33","article-title":"Centre National de R\u00e9f\u00e9rence des Pneumocoques. Rapports d&apos;activit\u00e9.","author":"P Geslin","year":"1992"},{"key":"ref34","article-title":"Centre National de R\u00e9f\u00e9rence des Pneumocoques.","author":"E Varon","year":"2003","journal-title":"Rapport d'activit\u00e9 2003: Epid\u00e9miologie 2002"},{"key":"ref35","article-title":"Centre National de R\u00e9f\u00e9rence des Pneumocoques.","author":"E Varon","year":"2005","journal-title":"Rapport d'activit\u00e9 2005: Epid\u00e9miologie 2004"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10096-003-1032-1","article-title":"Multicentre study of the molecular epidemiology, serotypes and antimicrobial susceptibility patterns of invasive <italic>Streptococcus pneumoniae<\/italic> invasive isolated from children in the Ile de France area.","volume":"23","author":"JW Decousser","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1128\/JCM.01653-06","article-title":"Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant <italic>Streptococcus pneumoniae<\/italic> over 4 years (2000 to 2004) of the PROTEKT US Study.","volume":"45","author":"DJ Farrell","year":"2007","journal-title":"J Clin Microbiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2307\/1403510","article-title":"Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV Model, as an example.","volume":"62","author":"SM Blower","year":"1994","journal-title":"International Statistical Review"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3201\/eid0503.990304","article-title":"Bacterial vaccines and serotype replacement: lessons from <italic>Haemophilus influenzae<\/italic> and prospects for <italic>Streptococcus pneumoniae<\/italic>.","volume":"5","author":"M Lipsitch","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/319604","article-title":"Measuring and interpreting associations between antibiotic use and penicillin resistance in <italic>Streptococcus pneumoniae<\/italic>.","volume":"32","author":"M Lipsitch","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3201\/eid0904.020213","article-title":"Bacterial resistance to penicillin G by decreased affinity of penicillin-binding proteins: a mathematical model.","volume":"9","author":"L Temime","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0140-6736(05)71043-6","article-title":"Incidence of macrolide resistance in <italic>Streptococcus pneumoniae<\/italic> after introduction of the pneumococcal conjugate vaccine: population-based assessment.","volume":"365","author":"DS Stephens","year":"2005","journal-title":"Lancet"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1128\/IAI.74.4.2187-2195.2006","article-title":"Antibody-independent, interleukin-17A\u2013mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide.","volume":"74","author":"R Malley","year":"2006","journal-title":"Infect Immun"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.mib.2006.07.002","article-title":"The biological cost of mutational antibiotic resistance: any practical conclusions?","volume":"9","author":"DI Andersson","year":"2006","journal-title":"Curr Opin Microbiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1086\/501367","article-title":"Incremental increase in fitness cost with increased beta-lactam resistance in pneumococci evaluated by competition in an infant rat nasal colonization model.","volume":"193","author":"K Trzcinski","year":"2006","journal-title":"J Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1128\/AAC.01161-06","article-title":"Fitness costs of fluoroquinolone resistance in <italic>Streptococcus pneumoniae<\/italic>.","volume":"51","author":"DE Rozen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref47","article-title":"Updated label for Ketek (telithromycin).","year":"2007"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJMp078032","article-title":"The FDA and the case of Ketek.","volume":"356","author":"DB Ross","year":"2007","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMc076135","article-title":"Ketek\u2013the FDA perspective.","volume":"356","author":"J Soreth","year":"2007","journal-title":"N Engl J Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3201\/eid1004.030754","article-title":"Consequences of bacterial resistance to antimicrobial agents.","volume":"10","author":"JC Desenclos","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/322623","article-title":"Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance.","volume":"33","author":"JF Moroney","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3201\/eid0702.010228","article-title":"Economic impact of antimicrobial resistance.","volume":"7","author":"JE McGowan Jr","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/499819","article-title":"Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.","volume":"42","author":"GH Talbot","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/AAC.48.2.605-607.2004","article-title":"Activities of cethromycin and telithromycin against recent North American isolates of <italic>Streptococcus pneumoniae<\/italic>.","volume":"48","author":"JH Jorgensen","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"9655","DOI":"10.1073\/pnas.0600636103","article-title":"Upgrading antibiotic use within a class: tradeoff between resistance and treatment success.","volume":"103","author":"YC Wang","year":"2006","journal-title":"Proc Natl Acad Sci U S A"}],"updated-by":[{"DOI":"10.1371\/annotation\/968c3453-14aa-4300-b743-cdb4f4c90a36","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2008,5,8]],"date-time":"2008-05-08T00:00:00Z","timestamp":1210204800000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0002089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T04:36:08Z","timestamp":1557549368000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0002089"}},"subtitle":[],"editor":[{"given":"J. Jaime","family":"Miranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,5,7]]},"references-count":55,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2008,5,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0002089","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/968c3453-14aa-4300-b743-cdb4f4c90a36","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,7]]}}}